Brain areas lipidomics in female transgenic mouse model of Alzheimer's disease

被引:4
|
作者
Ferre-Gonzalez, Laura [1 ]
Balaguer, Angel [2 ]
Roca, Marta [3 ]
Ftara, Artemis [4 ]
Lloret, Ana [5 ]
Chafer-Pericas, Consuelo [1 ]
机构
[1] Hlth Res Inst La Fe, Alzheimers Dis Res Grp, Avda Fernando Abril Martorell 106, Valencia 46026, Spain
[2] Univ Valencia, Fac Math, Valencia, Spain
[3] Hlth Res Inst La Fe, Analyt Unit, Valencia, Spain
[4] Univ Valencia, Valencia, Spain
[5] Univ Valencia, Hlth Res Inst INCLIVA, Fac Med, Dept Physiol, Valencia, Spain
关键词
EARLY ALZHEIMERS-DISEASE; AMYLOID-BETA; IN-VIVO; SPHINGOLIPIDS; HIPPOCAMPUS; METABOLISM; LIPIDS; RISK; SPHINGOMYELINS; CHOLESTEROL;
D O I
10.1038/s41598-024-51463-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Lipids are the major component of the brain with important structural and functional properties. Lipid disruption could play a relevant role in Alzheimer's disease (AD). Some brain lipidomic studies showed significant differences compared to controls, but few studies have focused on different brain areas related to AD. Furthermore, AD is more prevalent in females, but there is a lack of studies focusing on this sex. This work aims to perform a lipidomic study in selected brain areas (cerebellum, amygdala, hippocampus, entire cortex) from wild-type (WT, n = 10) and APPswe/PS1dE9 transgenic (TG, n = 10) female mice of 5 months of age, as a model of early AD, to identify alterations in lipid composition. A lipidomic mass spectrometry-based method was optimized and applied to brain tissue. As result, some lipids showed statistically significant differences between mice groups in cerebellum (n = 68), amygdala (n = 49), hippocampus (n = 48), and the cortex (n = 22). In addition, some lipids (n = 15) from the glycerolipid, phospholipid, and sphingolipid families were statistically significant in several brain areas simultaneously between WT and TG. A selection of lipid variables was made to develop a multivariate approach to assess their discriminant potential, showing high diagnostic indexes, especially in cerebellum and amygdala (sensitivity 70-100%, sensibility 80-100%).
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Early Biochemical and Morphological Modifications in the Brain of a Transgenic Mouse Model of Alzheimer's Disease: A Role for Peroxisomes
    Cimini, AnnaMaria
    Moreno, Sandra
    D'Amelio, Marcello
    Cristiano, Loredana
    D'Angelo, Barbara
    Falone, Stefano
    Benedetti, Elisabetta
    Carrara, Paolo
    Fanelli, Francesca
    Cecconi, Francesco
    Amicarelli, Fernanda
    Ceru, Maria Paola
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (04) : 935 - 952
  • [22] A PPARdelta Agonist Reduces Amyloid Burden and Brain Inflammation in a Transgenic Mouse Model of Alzheimer's Disease
    Kalinin, Sergey
    Richardson, Jill C.
    Feinstein, Douglas L.
    CURRENT ALZHEIMER RESEARCH, 2009, 6 (05) : 431 - 437
  • [23] Characterization of ATP Alternations in an Alzheimer's Disease Transgenic Mouse Model
    Zhang, Cheng
    Rissman, Robert A.
    Feng, June
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 44 (02) : 375 - 378
  • [24] Behavioral characterization of a new transgenic mouse model for Alzheimer's disease
    Aran, A
    Yavin, E
    Friedman, JE
    Dvir, E
    Finkelstein, E
    Duvdevani, R
    Haring, R
    Striem, S
    Hovel, D
    Kozak, A
    REVIEWS IN THE NEUROSCIENCES, 2005, 16 : S2 - S3
  • [25] Degradation of Bone Quality in a Transgenic Mouse Model of Alzheimer's Disease
    LLabre, Joan E.
    Gil, Cristianel
    Amatya, Neha
    Lagalwar, Sarita
    Possidente, Bernard
    Vashishth, Deepak
    JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 (12) : 2548 - 2565
  • [26] MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease
    Helpern, JA
    Lee, SP
    Falangola, MF
    Dyakin, VV
    Bogart, A
    Ardekani, B
    Duff, K
    Branch, C
    Wisniewski, T
    de Leon, MJ
    Wolf, O
    O'Shea, J
    Nixon, RA
    MAGNETIC RESONANCE IN MEDICINE, 2004, 51 (04) : 794 - 798
  • [27] BEHAVIORAL AND PATHOLOGICAL CHANGES IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE
    Dong Xian-hui
    Gao Wei-juan
    Kong Wei-na
    Chai Xi-qing
    INDIAN JOURNAL OF ANIMAL RESEARCH, 2014, 48 (04) : 389 - 394
  • [28] Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
    Bourasset, Fanchon
    Ouellett, Melissa
    Tremblay, Cyntia
    Julien, Carl
    Do, Tuan Minh
    Oddo, Salvatore
    LaFerla, Frank
    Calon, Frederic
    NEUROPHARMACOLOGY, 2009, 56 (04) : 808 - 813
  • [29] Intracerebroventricular passive immunization in transgenic mouse model of Alzheimer's disease
    Chauhan, NB
    Lichtor, T
    Siegel, GJ
    NEUROBIOLOGY OF AGING, 2004, 25 : S577 - S577
  • [30] Comorbidity of anxiety and Alzheimer's disease in the triple transgenic mouse model
    Varkonyi, Dorottya
    Sipos, Eszter
    Torok, Bibiana
    Zelena, Dora
    JOURNAL OF NEURAL TRANSMISSION, 2021, 128 (11) : 1781 - 1781